bioRxiv · 10.1101/2022.09.23.509253
Reprogramming of Iron Metabolism Confers Ferroptosis Resistance in ECM-Detached Cells
Abstract
Cancer cells often acquire resistance to cell death programs induced by loss of integrin-mediated attachment to extracellular matrix (ECM). Given that adaptation to ECM-detached conditions can facilitate tumor progression and metastasis, there is significant interest in effective elimination of ECM-detached cancer cells. Here, we find that ECM-detached cells are remarkably resistant to the induction of ferroptosis. While alterations in membrane lipid content are observed during ECM-detachment, it is instead fundamental changes in iron metabolism that underlie resistance of ECM-detached cells to ferroptosis. More specifically, our data demonstrate that levels of free iron are low during ECM-detachment due to changes in both iron uptake and iron storage. In addition, we establish that lowering the levels of iron storage proteins sensitizes ECM-detached cells to death by ferroptosis. Taken together, our data suggest that therapeutics designed to kill cancer cells by ferroptosis may be hindered by lack of efficacy towards ECM-detached cells.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
He, J., Abikoye, A. M., McLaughlin, B. P., Middleton, R. S., Sheldon, R., Jones, R. G., Schafer, Z. T.. 2022-09-25. Reprogramming of Iron Metabolism Confers Ferroptosis Resistance in ECM-Detached Cells. https://doi.org/10.1101/2022.09.23.509253
Cite the original work for its findings. Save a collection to share your selection of sources.